Zimmer Biomet Holdings, Inc. $ZBH Shares Sold by Boston Trust Walden Corp

Boston Trust Walden Corp reduced its stake in Zimmer Biomet Holdings, Inc. by 3.5% in the fourth quarter. Despite this, Zimmer Biomet reported strong Q4 results, beating revenue and EPS expectations, and announced a quarterly dividend of $0.24 per share. Various other institutional investors have either increased or initiated positions in the medical equipment provider.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments